University of Pittsburgh Medical Center
Welcome,         Profile    Billing    Logout  
 1110 Trials 
3043 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Reynolds, Charles
NCT00898755: Collecting and Storing Tissue From Young Patients With Cancer

Active, not recruiting
N/A
213
Canada, US
Cytology Specimen Collection Procedure, Cytologic Sampling, Laboratory Biomarker Analysis
Children's Oncology Group, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Central Nervous System Neoplasm, Ewing Sarcoma, Germ Cell Tumor, Leukemia, Lymphoma, Malignant Neoplasm, Neuroblastoma, Osteosarcoma, Retinoblastoma, Rhabdoid Tumor, Rhabdomyosarcoma, Soft Tissue Sarcoma
12/25
12/25
Donahoe, Michael
IMPALA-2, NCT04544293 / 2020-001263-85: Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Active, not recruiting
3
160
Europe, Canada, Japan, US, RoW
Molgramostim, Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF), Placebo
Savara Inc., Savara ApS,
Autoimmune Pulmonary Alveolar Proteinosis
11/23
11/24
Childs, Richard W
NCT03520647: Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Recruiting
2
56
US
Cyclophosphamide, Peripheral Blood Stem Cells
National Heart, Lung, and Blood Institute (NHLBI)
Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
06/25
06/28
NCT01656603: Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

Recruiting
2
9999
US
unlicensed CBU
New York Blood Center
Infusion Reactions
12/25
12/25
NCT01174108: Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

Recruiting
2
120
US
Miltenyi CD34 Reagent System, Donor derived G-CSF mobilized PBC
National Heart, Lung, and Blood Institute (NHLBI)
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome)
12/25
06/28
NCT05502783: Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Recruiting
2
20
US
fostamatinib
National Heart, Lung, and Blood Institute (NHLBI)
Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD
04/26
04/26
NCT05509582: Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

Enrolling by invitation
2
20
US
fostamatinib
National Heart, Lung, and Blood Institute (NHLBI)
Immune Mediated Anemia, Immune Mediated Thrombocytopenia, Chronic GVHD
12/28
12/28
NCT01861093: Safety Study of Cord Blood Units for Stem Cell Transplants

Recruiting
2
500
US
Cord Blood Units
National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID), National Cord Blood Program, New York Blood Center
Aplastic Anemia, Leukemia, Myelodysplastic Syndrome (MDS), Lymphoma
11/37
11/37
NCT03173937: Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

Recruiting
1/2
37
US
Omidubicel (former CordIn), Miltenyi CliniMACS(R) CD34 Reagent System
National Heart, Lung, and Blood Institute (NHLBI)
Severe Aplastic Anemia, Hypo-Plastic MDS, Myelodysplastic Syndrome (MDS)
04/25
03/28
NCT01553461: Transplants With Unlicensed Preserved Cord Blood

Recruiting
1/2
500
US
Cord Blood Transplant
National Heart, Lung, and Blood Institute (NHLBI)
Myelodysplastic Syndrome (MDS), Hematologic Neoplasms, Hematologic Diseases, Severe Aplastic Anemia
10/36
10/36
NCT03354390: HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

Active, not recruiting
1
17
US
cell infusion
National Heart, Lung, and Blood Institute (NHLBI), Loyola University Medical Center (LUMC)
Kidney Cancer
10/23
03/26
NCT00106925: Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Recruiting
N/A
1000
US
National Heart, Lung, and Blood Institute (NHLBI)
Graft-versus-leukemia, Graft vs Host Disease, Graft Rejection
 
 
NCT00071045: Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members

Recruiting
N/A
6000
US
National Heart, Lung, and Blood Institute (NHLBI)
Neoplasms, Hematologic Neoplasms, Healthy Volunteers
 
 
NCT01351545: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Recruiting
N/A
99999
US
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
Center for International Blood and Marrow Transplant Research, National Marrow Donor Program
Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL), Other Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Other Leukemia, Hodgkin Lymphoma, Non-hodgkin Lymphoma, Multiple Myeloma/ Plasma Cell Disorder (PCD), Inherited Abnormalities of Erythrocyte Differentiation or Function, Disorders of the Immune System, Autoimmune Diseases, Severe Aplastic Anemia
10/41
10/41
Kirkwood, John M
NCT00003641: High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Checkmark Data
May 2011 - May 2011: Data
Active, not recruiting
3
1150
Canada, US, RoW
interferon alfa-2b, recombinant interferon alfa, Intron-A, IFN-α 2b, NSC # 377523, observation, clinical observation
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), SWOG Cancer Research Network, Cancer and Leukemia Group B, NCIC Clinical Trials Group, Children's Oncology Group
Melanoma (Skin)
01/15
10/25
ATLAS-IT-05, NCT04796194: Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma

Active, not recruiting
2
20
Europe, US
LTX-315 in combination with pembrolizumab
Lytix Biopharma AS, Laboratory Corporation of America, OWL
Advanced Melanoma
12/24
12/24
NCT03743766: Nivolumab, BMS-936558 in Combination with Relatlimab, BMS-986016 in Patients with Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting

Completed
2
42
US
Relatlimab, BMS-986016, Nivolumab, BMS-936558, Relatlimab + Nivolumab, BMS-986016 and BMS-936558
John Kirkwood, Bristol-Myers Squibb
Melanoma
07/24
07/24
NCT02535078 / 2015-002971-12: Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma

Checkmark OS data from trial in combination with durvalumab and tremelimumab for cutaneous melanoma
Jun 2022 - Jun 2022: OS data from trial in combination with durvalumab and tremelimumab for cutaneous melanoma
Withdrawn
1/2
113
US
Tebentafusp (IMCgp100)
Immunocore Ltd, AstraZeneca
Malignant Melanoma
06/23
09/23
NCT04370587: A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Recruiting
1/2
64
US, RoW
T3011, T3011 + pembrolizumab
ImmVira Pharma Co. Ltd
Solid Tumor, Melanoma, HNSCC, Sarcoma, Squamous Cell Carcinoma, NSCLC
10/23
10/25
NCT04157517: A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

Terminated
1/2
45
US, RoW
Modakafusp Alfa, TAK-573, Pembrolizumab
Takeda
Neoplasms, Melanoma
12/23
12/23
NCT04688658: Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma

Active, not recruiting
1/2
13
US
Nivolumab, Opdivo, AG013736, Duvelisib, Copiktra
John Kirkwood, Secura Bio, Inc., Bristol-Myers Squibb
Unresectable Melanoma
02/24
12/28
NCT06599619: Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

Recruiting
N/A
30
US
Nivolumab, OPDIVO®, Pembrolizumab, Keytruda
John Kirkwood, Melanoma Research Foundation
Melanoma
12/25
12/25
Ramanathan, Ramesh K
NCT01959139: S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

Completed
1/2
126
US
PEGPH20, Pegylated Recombinant Human Hyaluronidase, Oxaliplatin, Eloxatin, NSC-266046, Leucovorin, leucovorin calcium, Irinotecan, CPT-11, NSC-616348, 5-fluorouracil, 5-FU, Adrucil, NSC-19893
SWOG Cancer Research Network, National Cancer Institute (NCI), Halozyme Therapeutics
Metastatic Pancreatic Adenocarcinoma
04/19
11/23
NCT05074472: A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Completed
1/2
35
US
ZB131
ZielBio, Inc.
Solid Tumor, Adult, Pancreatic Ductal; Adenocarcinoma, Ovarian Serous Adenocarcinoma, Biliary Cancer Metastatic, Ovarian Serous Cystadenocarcinoma
08/23
09/23
NCT02925689: Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Active, not recruiting
1
122
US, Canada
Dabrafenib, BRAF Inhibitor GSK2118436, GSK-2118436A, GSK2118436, Laboratory Biomarker Analysis, Pharmacogenomic Study, PHARMACOGENOMIC, Pharmacological Study
Mayo Clinic, GlaxoSmithKline, National Cancer Institute (NCI)
BRAF Gene Mutation, Hepatic Complication, Renal Failure, Solid Neoplasm
07/19
 
Edwards, Robert P
PROSPER-FM, NCT05243511: Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

Completed
3
275
US
Digital ACT, Digital Symptom Tracker
Swing Therapeutics, Inc.
Fibromyalgia
05/23
05/23
TNA-LBP, NCT04747314: Treating Negative Affect in Low Back Pain Patients

Recruiting
2/3
330
US
Antidepressant, AD: aripiprazole, bupropion, duloxetine, escitalopram, mirtazapine, sertraline, venlafaxine, Enhanced Fear Avoidance Rehabilitation, EFAR
Ajay Wasan, MD, Msc, National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Brigham and Women's Hospital, Mayo Clinic
Chronic Low Back Pain, Negative Affectivity
12/25
04/26
PATH, NCT04798469: Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism

Recruiting
2
150
US
Testosterone Undecanoate 250 MG/ML, Testosterone, Placebo, Control
Brigham and Women's Hospital
Opioid Use, Pain, Hypogonadism, Male
08/24
04/25
NCT03734692: Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer

Hourglass Jan 2024 - Mar 2024 : Q1'24 - Protocol-planned interim results readout for advanced recurrent ovarian cancer
Hourglass Nov 2023 - Nov 2023 : Data from P2 trial for recurrent platinum-sensitive ovarian cancer at SITC 2023
Checkmark Results from trial in combination with Ampligen
Mar 2022 - Mar 2022: Results from trial in combination with Ampligen
Recruiting
1/2
45
US
Rintatolimod, Ampligen, Pembrolizumab, Keytruda, Cisplatin, Platinol
Robert Edwards, AIM ImmunoTech Inc., Merck Sharp & Dohme LLC
Ovarian Cancer Recurrent
12/26
12/26
NCT02432378: Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines

Recruiting
1/2
25
US
Cisplatin + celecoxib + DC vaccine, Cisplatin + CKM + Celecoxib + DC Vaccine
Roswell Park Cancer Institute, AIM ImmunoTech Inc., National Cancer Institute (NCI), University of Pittsburgh
Cancer of Ovary, Cancer of the Ovary, Neoplasms, Ovarian, Ovarian Cancer, Ovary Cancer, Ovary Neoplasms
12/25
06/26
NCT02824276: Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain

Active, not recruiting
1
35
US
Oxycodone or morphine sulfate immediate release (MSIR), Oral Opioid Medication, Placebo Treatment
Brigham and Women's Hospital, National Institute on Drug Abuse (NIDA)
Low Back Pain
12/22
12/24
POKR-p, NCT04328701: Prediction of Outcomes Following Total Knee Replacement- Pilot

Active, not recruiting
N/A
40
US
Mindfulness-based Cognitive Behavioral Therapy
Brigham and Women's Hospital
Osteoarthritis, Knee, Knee Replacement
04/21
12/23
BEAT-Pain, NCT04607460: EMG Biofeedback Treatment for Chronic Low Back Pain, Cancer Pain and Migraines

Recruiting
N/A
330
US
JOGO Digital Therapeutics EMG Biofeedback for Lower Back Pain, JOGO Digital Therapeutics EMG Biofeedback for Persistent Post Mastectomy Pain, JOGO Digital Therapeutics EMG Biofeedback for Migraine
Brigham and Women's Hospital
Chronic Low-back Pain, Mastectomy, Lumpectomy, Migraine
12/23
12/23
AMOS, NCT06268522: Adjunctive Mindfulness During Opioid Tapering for patientS With Chronic Pain (The Study)

Recruiting
N/A
200
US
Mindfulness-Oriented Recovery Enhancement: (MORE) group, Psychoeducation
Brigham and Women's Hospital
Low Back Pain
06/24
06/24
NCT06157866: Cognitive Training to Enhance Brain Concordance During Acupuncture

Recruiting
N/A
100
US
Electroacupuncture, Cognitive Training, Education Training
Spaulding Rehabilitation Hospital, National Institutes of Health (NIH)
Fibromyalgia
06/27
06/27
Whitcomb, David C
NCT00004475: Genetic Linkage Study for Hereditary Pancreatitis

Completed
N/A
808
US
University of Pittsburgh
Pancreatitis
12/22
12/22
GREAT1, NCT04306939: Genomic Resources for Enhancing Available Therapies (.0) Study

Suspended
N/A
120000
US
venipuncture, Questionnaires, Additional Sample Collections
University of Pittsburgh
Chronic Pancreatitis, Inflammatory Bowel Diseases, Hepatitis, NASH - Nonalcoholic Steatohepatitis, Acute Pancreatitis, Rheumatoid Arthritis, Diabetes Mellitus, Dyslipidemias, Multiple Sclerosis, Irritable Bowel Syndrome, Chronic Pain, Chronic Disease, Chronic Kidney Diseases, Crohn Disease, Celiac Disease, Biliary Cirrhosis, Bile Acid Synthesis Defect, Gastritis, Cholecystitis, Cholelithiases, IPMN, Cyst Pancreas, Cystic Fibrosis, Pancreatic Exocrine Insufficiency, Diarrhea Chronic, Constipation - Functional, Constipation Chronic Idiopathic
12/25
12/25
PACT-CP, NCT05762445: PAtient-CenTric Chronic Pancreatitis Registry

Active, not recruiting
N/A
400
US
CorEvitas, Nestle Health Science
Chronic Pancreatitis
08/25
08/25
Sanchez, Pablo J
NCT01702805: Transfusion of Prematures Trial

Active, not recruiting
3
1824
US
Liberal Cell Transfusion, Restricted red cell transfusion
NICHD Neonatal Research Network, National Heart, Lung, and Blood Institute (NHLBI), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Infant, Newborn, Diseases, Infant, Extremely Low Birth Weight, Infant, Small for Gestational Age, Bronchopulmonary Dysplasia (BPD), Anemia
01/20
08/25
NCT01353313: Hydrocortisone for BPD

Active, not recruiting
3
800
US
Hydrocortisone, Placebo
NICHD Neonatal Research Network, National Center for Research Resources (NCRR), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI), National Center for Advancing Translational Sciences (NCATS)
Infant, Newborn, Infant, Small for Gestational Age, Infant, Very Low Birth Weight, Infant, Premature, Bronchopulmonary Dysplasia
09/20
01/25
MoCHA, NCT03340727: Moderately Preterm Infants With Caffeine at Home for Apnea () Trial

Terminated
3
827
US
Caffeine Citrate, Placebo
NICHD Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Apnea of Prematurity
01/23
03/23
BiB, NCT04545866: The Budesonide in Babies () Trial

Active, not recruiting
3
1160
US
budesonide (Pulmicort nebulizing suspension)., Pulmicort nebulizing suspension., surfactant (poractant alfa;Curosurf), poractant alfa;Curosurf
NICHD Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome, Prematurity; Extreme, Neonatal
09/24
12/26
NCT03456336: Management of the PDA Trial

Active, not recruiting
3
836
US
Active Treatment, Expectant Management
NICHD Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Infant, Premature, Patent Ductus Arteriosus, Infant, Newborn, Diseases, Patent Ductus Arteriosus After Premature Birth
04/25
05/27
NCT02951130: Milrinone in Congenital Diaphragmatic Hernia

Active, not recruiting
2
66
US
Milrinone, Milrinone Lactate Injection, Primacor, Placebo (5% Dextrose), D5W
NICHD Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Congenital Diaphragmatic Hernia, Persistent Pulmonary Hypertension of the Newborn, Hypoxemic Respiratory Failure, Pulmonary Hypoplasia
09/24
03/25
NCT06061081: A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1

Suspended
2
26
Europe, US, RoW
VH3739937, Placebo
ViiV Healthcare
HIV Infections
11/24
11/24
NCT04318587: Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation

Terminated
N/A
40
US
Allosure
Pablo Sanchez, CareDx
Lung Transplant Failure and Rejection
12/22
12/23
NeoPlaTT, NCT06676904: Neonatal Platelet Transfusion Threshold Trial

Not yet recruiting
N/A
2433
US
Higher Platelet Transfusion Threshold, Liberal Transfusion Threshold, Lower Platelet Transfusion Threshold, Restrictive Transfusion Threshold
NICHD Neonatal Research Network, National Heart, Lung, and Blood Institute (NHLBI)
Thrombocytopenia, Neonatal, Platelet Transfusion, Infant, Newborn, Diseases, Infant, Extremely Low Birth Weight, Infant, Small for Gestational Age, Thrombosis
01/31
04/31
NCT03927833: Cycled Phototherapy

Recruiting
N/A
1700
US
Phototherapy lights
NICHD Neonatal Research Network, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Hyper Bilirubinemia, Premature Infant
07/25
07/25
NCT05547698: A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation

Recruiting
N/A
228
Europe, US
Off-pump lung transplantation, Venoarterial ECMO lung transplantation
Mayo Clinic
Lung Transplant
09/25
09/25
NCT06082453: Modernizing Perinatal Syphilis Testing

Recruiting
N/A
924
US
Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum, Aptima Treponema pallidum transcription-mediated amplification (TMA) assay for detection of Treponema pallidum, Center for Disease Control (CDC) Sexually Transmitted Infections (STI) 2021 Treatment Guidelines for diagnosis of syphilis
The University of Texas Health Science Center, Houston, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Syphilis
11/27
11/27
NCT00063063: Generic Database of Very Low Birth Weight Infants

Recruiting
N/A
80000
US
NICHD Neonatal Research Network, National Center for Research Resources (NCRR), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature
03/30
03/30
NCT00009633: Follow-up Visit of High Risk Infants

Recruiting
N/A
68000
US
NICHD Neonatal Research Network, National Center for Research Resources (NCRR), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature
03/30
03/30
Deutsch, Melvin
NCT01465100: Liver Cell Transplant for Phenylketonuria

Terminated
1/2
1
US
Preparative Radiation Therapy, Hepatocyte Transplant, Immunosuppression, Liver Evaluation, Neuro-psychological Assessment, Whole body Phe oxidation testing, Liver Biopsy
Ira Fox
Phenylketonuria
08/15
06/16
NCT01360606: Stereotactic Body Radiation Therapy (SBRT) for Liver Mets

Completed
N/A
9
US
Stereotactic Body Radiation Therapy, CyberKnife, Trilogy, True Beam, Radiosurgery
Susannah Ellsworth
Liver Metastases
07/18
02/21
Pollock, Bruce G
CaCBT, NCT04010890: Development and Evaluation of Culturally Adapted CBT for South Asian Canadians

Recruiting
N/A
140
Canada
Culturally adapted CBT, CaCBT
Centre for Addiction and Mental Health
Depression, Anxiety
03/22
03/22
StaN, NCT03672201: Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia

Active, not recruiting
N/A
187
Canada
Non-Pharmacological Intervention, Behavioural Intervention, Pharmacological Intervention
Centre for Addiction and Mental Health, University of Calgary, Lawson Health Research Institute, Douglas Mental Health University Institute
Alzheimer's Disease, Alzheimer Dementia (AD), Aggression
03/23
12/24
Chatta, Gurkamal S
PSMAddition, NCT04720157 / 2020-003968-56: An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC

Jan 2024 - Dec 2024: Primary data from PSMAddition trial for metastatic hormone sensitive prostate cancer
Active, not recruiting
3
1145
Europe, Canada, Japan, US, RoW
177Lu-PSMA-617, 68Ga-PSMA-11, ARDT, ADT
Novartis Pharmaceuticals, Alliance Foundation Trials, LLC., RTOG Foundation, Inc.
Prostatic Neoplasms
07/25
02/26
S1802, NCT03678025: Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Recruiting
3
1273
Europe, US, RoW
Abiraterone, CB 7598, Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Degarelix, FE200486, Firmagon, Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate, Flutamide, 4'-Nitro-3'-trifluoromethylisobutyranilide, Apimid, Cebatrol, Chimax, Cytomid, Drogenil, Euflex, Eulexine, Flucinom, Flucinome, Flugerel, Fluken, Flulem, FLUT, Fluta-Gry, Flutabene, Flutacan, Flutamex, Flutamin, Flutan, Flutaplex, Fugerel, Grisetin, Niftolide, Oncosal, Profamid, Propanamide, 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, Prostacur, Prostadirex, Prostica, Prostogenat, SCH 13521, Tafenil, Tecnoflut, Testotard, Goserelin Acetate, ZDX, Zoladex, Histrelin Acetate, Supprelin, Vantas, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Nilutamide, Anandron, Nilandron, RU-23908, Orchiectomy, Castration, Male Castration, Male Gonadectomy, orchidectomy, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisonum, Prednitone, Promifen, Servisone, SK-Prednisone, Quality-of-Life Assessment, Quality of Life Assessment, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, irradiation, Radiation, Radiotherapeutics, RADIOTHERAPY, RT, Therapy, Radiation, Radical Prostatectomy, Prostatovesiculectomy, Triptorelin, 6-D-Tryptophan-LH-RH, 6-D-Tryptophanluteinizing Hormone-releasing Factor, AY-25650, CL-118,532, Decapeptyl, Detryptoreline
SWOG Cancer Research Network, National Cancer Institute (NCI)
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
04/28
10/31
NCT04064190: Vactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint Inhibition

Withdrawn
2
48
US
Vactosertib(TEW-7197)/ Durvalumab
MedPacto, Inc., AstraZeneca
Urothelial Carcinoma Recurrent, Advanced Urothelial Carcinoma
12/23
12/24
NCT02555189: Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Completed
1/2
46
US
Enzalutamide, Xtandi, MDV3100, 915087-33-1, ASP9785, Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-, Ribociclib, LEE011, 1211441-98-3, 7-Cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide, Kisqali, LEE-011, Laboratory Biomarker Analysis, Pharmacological Study, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Biopsy, BIOPSY_TYPE, Bx, Echocardiography, EC, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, MUGA, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Bone Scan, Bone Scintigraphy, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, computerized axial tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT SCAN, tomography, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, nuclear magnetic resonance imaging, sMRI, Structural MRI
Sidney Kimmel Cancer Center at Thomas Jefferson University, Novartis, Prostate Cancer Clinical Trials Consortium
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone, Stage IV Prostate Cancer AJCC v7
12/22
09/23
NCT02744287: Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors

Feb 2023 - Feb 2023: Early P1 data in patients with metastatic castration-resistant prostate cancer at ASCO-GU 2023
Checkmark Updated data from BP-012 trial
Oct 2020 - Oct 2020: Updated data from BP-012 trial
Checkmark From BP-012 trial in advanced solid tumors at ASCO 2019 [screenshot]
May 2019 - Jun 2019: From BP-012 trial in advanced solid tumors at ASCO 2019 [screenshot]
More
Suspended
1/2
151
US
BPX-601, Rimiducid, AP1903
Bellicum Pharmaceuticals
Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer
10/25
02/26
PRESERVE-006, NCT05682443: ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC

Recruiting
1/2
144
US
ONC-392, A humanized anti-CTLA4 IgG1 monoclonal antibody, Gotistobart, lutetium Lu 177 vipivotide tetraxetan, IV infusion, Q6W for up to 6 doses., Pluvicto
OncoC4, Inc., Prostate Cancer Clinical Trials Consortium
Metastatic Castration-resistant Prostate Cancer
06/26
06/27
NCI-2018-02448, NCT03751436: Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Completed
1
10
US
Enzalutamide, ASP9785, MDV3100, Xtandi, Venetoclax, ABT-0199, ABT-199, ABT199, GDC-0199, RG7601, Venclexta
Roswell Park Cancer Institute, AbbVie
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue, Prostate Carcinoma Metastatic in the Bone, PSA Progression, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
07/22
08/23
NCT06305598: Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer

Recruiting
1
14
US
Biopsy, BIOPSY_TYPE, Bx, Bone Scan, Bone Scintigraphy, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Luprodex Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Lutrate, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Survey Administration, Testosterone Cypionate, depAndro, Depo-Testosterone, Depotest, Depovirin, Pertestis, Virilon
Roswell Park Cancer Institute
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
12/26
12/27
NCT05037500: Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Active, not recruiting
1
8
US
Decitabine and Cedazuridine, ASTX727, C-DEC, CDA Inhibitor E7727/Decitabine Combination Agent ASTX727, Cedazuridine/Decitabine Combination Agent ASTX727, Cedazuridine/Decitabine Tablet, DEC-C, Inqovi, Enzalutamide, ASP9785, MDV3100, Xtandi
Roswell Park Cancer Institute, National Comprehensive Cancer Network
Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
03/25
03/26
NCT03880422: Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors

Recruiting
N/A
50
US
Dietary Intervention, Dietary Modification, intervention, dietary, Nutrition Intervention, Nutrition Interventions, Nutritional Interventions, Educational Intervention, Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational, Exercise Intervention, Quality-of-Life Assessment, Quality of Life Assessment, Survey Administration
Roswell Park Cancer Institute
Cancer Survivor, Obesity, Overweight, Prostate Adenocarcinoma, Stage A Prostate Cancer, Stage B Prostate Cancer, Stage C Prostate Cancer, Stage D Prostate Cancer, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage IIC Prostate Cancer, Stage III Prostate Cancer, Stage IIIA Prostate Cancer, Stage IIIB Prostate Cancer, Stage IIIC Prostate Cancer, Stage IV Prostate Cancer, Stage IVA Prostate Cancer, Stage IVB Prostate Cancer
05/29
05/29
IRONMAN, NCT03151629: International Registry for Men With Advanced Prostate Cancer

Recruiting
N/A
5000
Europe, Canada, US, RoW
Standard of Care
Prostate Cancer Clinical Trials Consortium
Prostate Cancer
01/31
01/32
Boeckh, Michael
GRAIL^3, NCT04706507: Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis

Active, not recruiting
3
500
US
IV Ganciclovir, Cytovene
Fred Hutchinson Cancer Center, National Heart, Lung, and Blood Institute (NHLBI)
Acute Respiratory Failure
10/24
08/27
Stewart, Andrew F
OHP-II, NCT05915299: US National OCS Heart Perfusion (OHP) Registry

Recruiting
N/A
100000
US
OCS Heart
TransMedics
Heart Transplant
08/29
08/33
Lieberman, Frank S
ACTION, NCT05580562: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the Study)

Calendar Jan 2026 - Dec 2026: Final data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma
Calendar Jan 2025 - Mar 2025: Interim data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma
Recruiting
3
450
Europe, Canada, Japan, US, RoW
Dordaviprone (ONC201), Dordaviprone (ONC201) + Placebo, Placebo
Chimerix
H3 K27M, Glioma
08/26
08/26
HTX-GBM-01, NCT05736406: A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

Recruiting
1/2
12
US
5-ALA HCl intraoperative Photodynamic Therapy (PDT) at 200 J/cm^2, Pentalafen®, 5-aminolevulinic acid hydrochloride, Heliance® Solution, 5-ALA PDT, 5-ALA HCl intraoperative Photodynamic Therapy (PDT) at 400 J/cm^2
Hemerion Therapeutics
Primary Glioblastoma
12/25
07/26
TRIDENT, NCT04471844: Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant with RT & TMZ for the Treatment of Newly Diagnosed GBM

Active, not recruiting
N/A
982
Europe, Canada, Japan, US, RoW
Optune®
NovoCure Ltd.
Glioblastoma Multiforme
01/26
01/26
McDermott, Mary
NICE, NCT03743636: Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease

Completed
3
90
US
Nicotinamide riboside, NR, Niagen, Resveratrol, Placebo
Northwestern University, American Heart Association
Peripheral Artery Disease
05/23
05/23
PERMET, NCT03054519: Improve PAD PERformance With METformin

Recruiting
3
212
US
Metformin, Placebo
Northwestern University
Peripheral Artery Disease
07/25
12/25
IMPACT PAD, NCT06686121: Improving Mobility After Revascularization in Peripheral Artery Disease

Not yet recruiting
3
386
US
Home Based Exercise, Nitrate Rich Beetroot Juice, Attention Control, Placebo Beetroot Juice Without Nitrate
Northwestern University
Peripheral Artery Disease, Intermittent Claudication, Peripheral Vascular Disease, Mobility Limitation, Revascularization
02/32
08/32
COCOA-PAD II, NCT04794530: The Trial

Recruiting
3
190
US
cocoa flavanols, placebo
Northwestern University, National Institute on Aging (NIA), University of Minnesota, University of Chicago
Peripheral Artery Disease
05/26
12/26
SMART PAD, NCT06032065: SMART Exercise for PAD

Recruiting
3
210
US
Supervised Treadmill Exercise, Home-Based Exercise, Nitrate-rich beetroot Juice
Northwestern University
Peripheral Arterial Disease, Aging, Peripheral Vascular Diseases, Walking, Difficulty
11/28
03/29
NCT03363165: Hepatocyte Growth Factor to Improve Functioning in PAD

Completed
2
39
US
VM202, Placebo
Northwestern University, National Institute on Aging (NIA), Helixmith Co., Ltd.
Peripheral Artery Disease
02/23
09/23
GIFTII, NCT04377126: Unacylated Ghrelin to Improve Functioning in PAD

Recruiting
2
30
US
Ghrelin, Unacylated ghrelin, Placebo, Inactive substance
Northwestern University, National Institute on Aging (NIA)
Peripheral Artery Disease
02/25
02/25
FIRST, NCT06399809: Fisetin to Reduce Senescence and Mobility Impairment in PAD

Recruiting
2
34
US
Fisetin, Placebo
Northwestern University
Peripheral Arterial Disease, Aging, Peripheral Vascular Diseases, Walking, Difficulty, Claudication
11/26
06/27
RESIST, NCT06657976: Response to Exercise and Nitric Oxide in PAD

Recruiting
2
200
US
Supervised Treadmill Exercise, Supervised Exercise Therapy, Attention Control, Control, Nitrate-Rich Beetroot Juice + supervised exercise therapy, Placebo + supervised exercise therapy
Northwestern University, National Institute on Aging (NIA)
Peripheral Artery Disease, Exercise, Intermittent Claudication, Nitric Oxide
10/30
05/31
LIGHT PAD, NCT06165016: Far Red Light to Improve Functioning in PAD

Recruiting
N/A
32
US
Far red light therapy, Sham light therapy
Northwestern University
Peripheral Artery Disease, Peripheral Vascular Disease, Aging, Walking, Difficulty
01/27
06/27
INTERCEDE, NCT03871075: Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease

Recruiting
N/A
230
US
intermittent pneumatic compression, IPC, exercise, Sham device, Health Education
Northwestern University, National Institute on Aging (NIA)
Peripheral Artery Disease
07/26
11/26
ENLIGHTEN PAD, NCT06399900: ENhancing Exercise with LIGHT to Improve Functioning in PAD

Recruiting
N/A
32
US
Far red light therapy, Sham light therapy, Home-based walking exercise
Northwestern University
Peripheral Artery Disease, Peripheral Vascular Disease, Aging, Walking, Difficulty
09/26
01/27
PROVE, NCT04228978: Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

Recruiting
N/A
212
US
Weight loss, Exercise
Northwestern University, National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University
Peripheral Artery Disease, Overweight or Obesity
02/27
05/27
BEET PAD, NCT05624125: BEETroot Juice to Reverse Functional Impairment in PAD

Recruiting
N/A
210
US
Beetroot juice, Placebo
Northwestern University, University of Virginia, University of Chicago, National Institute on Aging (NIA)
Peripheral Artery Disease
04/28
10/28
McMahon, Deborah
NETI, NCT04985760: Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy

Recruiting
1
32
US
Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, HIV-1 Trimer 4571 Vaccine, VRC-HIVRGP096-00-VP, Placebo control for Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, Phosphate buffered saline, Trimer 4571 vaccine 500mcg with 500mcg alum adjuvant, Placebo control for Trimer 4571 vaccine 500mcg with 500mcg alum adjuvant
Madhu Chhanda Choudhary, National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
10/25
11/25
DC-HIV04, NCT03758625: Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure

Active, not recruiting
1
40
US
a1DC + inactivated whole autologous HIV, a1DC + conserved HIV peptides, a1DC + no antigen, pgDC + inactivated whole autologous HIV, pgDC + conserved HIV peptides, pgDC + no antigen
Sharon Riddler, National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
03/25
03/25
NCT05404750: Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

Recruiting
N/A
768
US
Harm Reduction
University of Pittsburgh, Allegheny Health Network Research Institute, University of Alabama at Birmingham, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)
Human Immunodeficiency Virus, Substance Use, Stigma, Social
06/26
06/26
Handen, Benjamin L
DS+ADHD Pilot, NCT04219280: Evaluating Treatment of ADHD in Children with Down Syndrome

Recruiting
4
100
US
Quillivant XR, Placebo
Children's Hospital Medical Center, Cincinnati, University of California, Davis, University of Pittsburgh Medical Center, Boston Children's Hospital, Boston, MA, USA
Down Syndrome, ADHD
09/25
09/25
NCT05916339: AWARE: Management of ADHD in Autism Spectrum Disorder

Recruiting
4
500
Canada, US
Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
Daniel Coury, Patient-Centered Outcomes Research Institute, University of California, Irvine, Holland Bloorview Kids Rehabilitation Hospital, Children's Hospital of Philadelphia, University of Rochester Golisano Children's Hospital, Nationwide Children's Hospital, Children's Hospital Medical Center, Cincinnati, University of Pittsburgh, Children's Hospital Los Angeles, University of Virginia, University of Alberta, Massachusetts General Hospital, MaineHealth, University of Michigan
ADHD, Autism Spectrum Disorder
01/27
12/27
NCT05418023: Validation of a Salivary miRNA Diagnostic Test for ASD

Recruiting
N/A
6604
US
Salivary Collection, Adaptive Assessment, Medical and Demographic questionnaire, Autism Assessment, Intellectual Development Assessment
Quadrant Biosciences Inc., University of California, Irvine, Holland Bloorview Kids Rehabilitation Hospital, Children's Hospital of Philadelphia, MetroHealth Medical Center, University of Rochester, Nationwide Children's Hospital, Children's Hospital Medical Center, Cincinnati, University of Pittsburgh, University of Massachusetts, Worcester, Children's Hospital Los Angeles, Prisma Health-Upstate, University of Virginia, State University of New York - Upstate Medical University, Rush University, Seattle Children's Hospital, Drexel University, Emory University
Autism Spectrum Disorder, Developmental Delay
07/23
07/23
CST, NCT06038799: Caregiver Skills Training: Comparing Clinician Training Methods

Recruiting
N/A
35
US
Caregiver Skills Training (CST)
University of Pittsburgh, Autism Speaks
Parenting
12/24
12/24
TRC-DS, NCT04165109: Trial-Ready Cohort-Down Syndrome

Recruiting
N/A
450
Europe, US
Flutafuranol, [18F]NAV4694, NAV4694, Pittsburgh Compound (PIB), [11C]-PIB, PIB, MK6240, [18F]MK-6240
University of Southern California, National Institute on Aging (NIA), Alzheimer's Clinical Trials Consortium, Alzheimer's Therapeutic Research Institute
Down Syndrome, Alzheimer Disease, Dementia
12/25
12/25
Greenspan, Susan L
PROUD, NCT02753283: Preventing Osteoporosis Using Denosumab

Completed
4
201
US
denosumab, Prolia, Placebo, Calcium and Vitamin D
Susan L. Greenspan, National Institutes of Health (NIH), National Institute on Aging (NIA)
Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures
08/23
08/23
NCT05058976: Romosozumab Use to Build Skeletal Integrity

Recruiting
4
200
US
Romosozumab, Evenity, Placebo, Zoledronic acid, Reclast, Calcium and Vitamin D
Susan L. Greenspan, National Institutes of Health (NIH), National Institute on Aging (NIA)
Osteoporosis, Osteoporosis, Postmenopausal, Osteoporosis Fracture
09/27
09/27
Shin, Dong M
NCT03840291: Resolution of Thrombi in Left Atrial Appendage With Edoxaban

Completed
4
36
RoW
Edoxaban, Lixiana®
Keimyung University Dongsan Medical Center, Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company
Atrial Fibrillation, Left Atrial Appendage Thrombosis
10/23
08/24
LIBRETTO-531, NCT04211337 / 2019-001978-28: A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

Active, not recruiting
3
291
Europe, Canada, Japan, US, RoW
Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib
Loxo Oncology, Inc., Eli Lilly and Company
Medullary Thyroid Cancer
05/23
02/26
RODIN, NCT05041010: Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz

Recruiting
3
496
RoW
Neu2000KWL group, Placebo group
GNT Pharma
Ischemic Stroke
06/24
01/25
NCT03200340: EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation

Completed
2
105
US
EC-18, EC-18 soft capsules, Placebo, Placebo capsule
Enzychem Lifesciences Corporation
Stomatitis
05/21
05/21
 

Download Options